All In MedTech

Device Trial Radar · NCT04392349

Clinical Study - ES 900 - 2020-2

Last checked: Nov 19, 2026Latest source record: Mar 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

29

Actual

Start

Jul 1, 2020

Primary completion

Aug 20, 2020

Study completion Dec 10, 2020

Sponsor

Lead sponsor
Haag-Streit AGNot on our public-company list
Sponsor type
Industry
First posted
May 18, 2020

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Diagnostic
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The EYESTAR 900 with software version i9.5.1.0 includes new analysis functionality. Since its clinical performance cannot be assessed based solely on clinical literature as found in the Clinical Evaluation Report, further data from a clinical trial is required. The objective of this trial is to assess the clinical performance of the new features of the EYESTAR 900 with software version i9.5.1.0. This study is a necessary part of the clinical evaluation process of the investigational device. The results of this study are used for the clinical evaluation, and for reporting of in-vivo repeatabilities in the instructions for use of the investigational device, as required by topography standards.

Conditions

  • Cataract
  • Keratoconus

Interventions

  • Haag-Streit EYESTAR 900Device

    The EYESTAR 900 is a new device developed by HAAG-STREIT AG which utilises Optical Coherence Tomography (OCT) for quantitative measurements of the geometry of the eye. As a successor to the LENSTAR 900, it represents the most recent in a series of successful biometry devices.

  • Tomey CASIA 2Device

    The CASIA2 is a testing application for Cataract / Glaucoma / Cornea Surgery already established on the market. It is a representative device for measurement of anterior and posterior corneal curvature (anterior and posterior corneal topography) by optical coherence tomography, and for measurement of crystalline lens tilt by optical coherence tomography.

  • Oculus PENTACAM HRDevice

    The Pentacam HR is a high-resolution rotating Scheimpflug camera system for anterior segment analysis already established on the market. It is used as representative device for advanced anterior segment analysis such as anterior and posterior corneal topography and corneal pachymetry.

  • Zeiss ATLAS 9000Device

    ATLAS is a corneal topography system used as representative device for measurement of anterior corneal curvature (anterior corneal topography).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. In-vivo RepeatabilityTime frame: 3 months
  2. Limits of AgreementTime frame: 3 months
  3. Confidence Interval of DifferencesTime frame: 3 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University Hospital Basel

    Basel, Switzerland

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.